![](/cdn/assets/images/search/clock.png)
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Utek Corp | LSE:UTK | London | Ordinary Share | COM STK USD0.01 |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 250.00 | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
TIDMUTK RNS Number : 2507R UTEK Corporation 28 April 2009 Utek Corporation ("Utek" or the "Company") Restatement of Annual Accounts The Company has filed a Form 8-K with the SEC in relation to an adjustment and restatement to the Company's annual accounts for the year ended 31 December 2008, the details of which are set out below as extracted from Form 8-K. "Item 4.02. Non-Reliance on Previously Issued Financial Statements or a Related Audit Report or Completed Interim Review. On April 22, 2009, the Audit Committee of our Board of Directors, with the concurrence of our executive officers, concluded that we will need to restate our previously issued financial statements for fiscal year 2008, and the interim periods contained therein, and that such financial statements should no longer be relied upon. In addition, our prior earnings and press releases and similar communications should no longer be relied upon to the extent they relate to these financial statements. Accordingly, we will restate the financial statements for fiscal year 2008 included in our annual report on Form 10-K for the fiscal year ended December 31, 2008, and the financial statements for the 2008 interim periods included in our Form 10-Qs for the quarters ended March 31, 2008, June 30, 2008 and September 30, 2008, to make the accounting adjustment described in more detail below. Specifically, we determined that pursuant to Statement of Financial Accounting Standards No. 5, "Accounting for Contingencies," we should have accrued and reported as a liability in our 2008 financial statements a payment obligation which arose in connection with our entry into an employment agreement on March 1, 2008 with our then chief executive officer, Clifford M. Gross, Ph.D. Pursuant to the terms of the employment agreement, Dr. Gross was entitled to receive a payment, at the end of the term of the agreement or if Dr. Gross is terminated for any reason, equal to the number of years Dr. Gross had worked for us times $100,000 per year, "grossed-up" to cover any tax liability. At the time of our entry into the employment agreement, Dr. Gross had been employed by us for 10.5 years. Given that the payment obligation was certain to be paid at some point in the future (i.e., when the employment agreement was not renewed at some future date) and the amount of the payment obligation was determinable at the time of entry into the employment agreement, we should have accrued and reported such payment obligation as a liability in our financial statements for the quarter ended March 31, 2008 as well as in our subsequent interim and annual financial statements for 2008. As previously disclosed in our Form 10-K for the year ended December 31, 2008, Dr. Gross retired from his position as our chief executive officer on March 1, 2009, following the conclusion of the term of the employment agreement, including a subsequent extension to the term thereof. Moreover, as disclosed in a Form 8-K filed with the SEC on April 13, 2009, we entered into a separation agreement with Dr. Gross that modified the payment terms, but not the monetary obligation amount that Dr. Gross was entitled to receive pursuant to the employment agreement. The Audit Committee of our Board of Directors and our executive officers have discussed the matters disclosed in this Item 4.02 Form 8-K with Pender Newkirk & Company, LLP, our independent registered public accounting firm." Pursuant to the separation agreement referred to above, the Company will immediately pay Dr. Gross $600,000 and cover his tax liabilities with respect to such payment. In addition, the Company will issue to Dr. Gross a $550,000 promissory note. The promissory note will not bear any interest and will be due and payable on March 1, 2010. Pursuant to the terms of the promissory note, the Company may elect to transfer certain equity interests in one of its portfolio companies, which owns real estate located in Florida, to Dr. Gross in lieu of making the $550,000 cash payment upon maturity of the promissory note. The impact of the restatement is expected to increase the loss after tax for 2008 by approximately $1.6 million. The annual report and accounts for the year ended 31 December 2008 has been posted to shareholders and is available on the Company's website www.utekcorp.com, however, a restated annual report will be sent to shareholders in due course. +-----------------------------------------------+ | Contacts: | +-----------------------------------------------+ | www.utekcorp.com | +-----------------------------------------------+ | | +-----------------------------------------------+ | USA: | +-----------------------------------------------+ | Allen & Caron, Inc. - PR advisers | +-----------------------------------------------+ | Brian Kennedy | +-----------------------------------------------+ | brian@allencaron.com | +-----------------------------------------------+ | +1 212-691-8087 | +-----------------------------------------------+ | | +-----------------------------------------------+ | UK: | +-----------------------------------------------+ | Fairfax I.S. PLC - AIM Nominated adviser and | | Broker | +-----------------------------------------------+ | Jeremy Porter | +-----------------------------------------------+ | + 44 (0)20 7598 5368 | +-----------------------------------------------+ This information is provided by RNS The company news service from the London Stock Exchange END MSCBIGDSDGDGGCR
1 Year Utek Corp Chart |
1 Month Utek Corp Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions